tiprankstipranks
Trending News
More News >
Perfect Medical Health Management Limited (HK:1830)
:1830
Hong Kong Market

Perfect Medical Health Management Limited (1830) AI Stock Analysis

Compare
8 Followers

Top Page

HK

Perfect Medical Health Management Limited

(1830)

Rating:73Outperform
Price Target:
Perfect Medical Health Management Limited exhibits a strong financial foundation with stable revenue growth and profitability. However, the technical analysis suggests a cautious approach due to bearish trends in moving averages and negative MACD, which may offset the attractive valuation and high dividend yield. Overall, the stock presents a balanced profile of strengths and potential risks.

Perfect Medical Health Management Limited (1830) vs. iShares MSCI Hong Kong ETF (EWH)

Perfect Medical Health Management Limited Business Overview & Revenue Model

Company DescriptionPerfect Medical Health Management Limited (1830) is a healthcare service provider based in Hong Kong. The company specializes in offering a wide range of medical and health management services, including preventive healthcare, medical consultations, and health assessments. Perfect Medical Health Management Limited operates clinics and healthcare facilities, focusing on delivering quality medical care and promoting health and wellness in the communities they serve.
How the Company Makes MoneyPerfect Medical Health Management Limited generates revenue primarily through the provision of healthcare services and health management programs. The company's key revenue streams include fees for medical consultations, health assessments, and preventive healthcare services offered at its clinics and healthcare facilities. Additionally, the company may engage in strategic partnerships with other healthcare providers or organizations to enhance its service offerings, thereby potentially increasing its customer base and revenue. Factors such as the growing demand for healthcare services, an aging population, and increased health awareness contribute to the company's earnings.

Perfect Medical Health Management Limited Financial Statement Overview

Summary
Income Statement
Balance Sheet
Cash Flow
Breakdown
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income StatementTotal Revenue
1.39B1.39B1.35B1.09B1.24B
Gross Profit
911.37M662.60M689.93M553.44M715.02M
EBIT
382.38M368.81M383.79M302.87M453.79M
EBITDA
596.91M592.40M602.84M474.13M617.30M
Net Income Common Stockholders
315.80M315.64M305.25M284.63M360.16M
Balance SheetCash, Cash Equivalents and Short-Term Investments
567.40M656.85M454.37M532.89M671.09M
Total Assets
1.22B1.30B1.28B1.48B1.30B
Total Debt
268.73M240.35M311.07M261.60M252.00M
Net Debt
-298.68M-206.28M-143.08M-236.98M-314.45M
Total Liabilities
725.00M684.02M786.93M795.52M620.25M
Stockholders Equity
497.51M612.27M494.27M684.85M679.00M
Cash FlowFree Cash Flow
445.50M533.81M372.16M527.69M549.00M
Operating Cash Flow
497.12M560.55M516.71M605.91M645.44M
Investing Cash Flow
162.56M-222.51M8.05M-300.82M-75.22M
Financing Cash Flow
-520.97M-335.02M-565.97M-394.41M-330.45M

Perfect Medical Health Management Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2.34
Price Trends
50DMA
2.24
Positive
100DMA
2.21
Positive
200DMA
2.28
Positive
Market Momentum
MACD
0.03
Positive
RSI
59.23
Neutral
STOCH
66.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1830, the sentiment is Positive. The current price of 2.34 is above the 20-day moving average (MA) of 2.32, above the 50-day MA of 2.24, and above the 200-day MA of 2.28, indicating a bullish trend. The MACD of 0.03 indicates Positive momentum. The RSI at 59.23 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1830.

Perfect Medical Health Management Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$32.93B11.9114.56%5.03%-5.37%6.28%
73
Outperform
HK$2.94B10.1358.52%12.22%-9.98%-12.36%
66
Neutral
HK$20.01B21.5425.73%168.87%150.80%
62
Neutral
$6.88B11.322.90%3.87%2.70%-24.57%
50
Neutral
HK$404.53M-57.25%95.39%30.86%
45
Neutral
$14.78B84.760.96%1.01%
36
Underperform
HK$161.78M-7.42%10.93%-159.62%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1830
Perfect Medical Health Management Limited
2.34
0.25
11.96%
HK:1520
Virtual Mind Holding Company Limited
0.51
0.16
45.71%
HK:1415
Cowell e Holdings Inc.
23.20
2.90
14.29%
HK:1312
Kontafarma China Holdings Ltd
0.03
-0.01
-25.00%
HK:1833
Ping An Healthcare and Technology Company
6.84
2.76
67.73%
HK:1513
Livzon Pharmaceutical Group
29.50
3.89
15.21%

Perfect Medical Health Management Limited Corporate Events

Perfect Medical Grants Share Options to Enhance Employee Commitment
Jan 7, 2025

Perfect Medical Health Management Limited has announced the grant of 3,768,000 share options to eligible employees under its share option scheme. This initiative, effective from January 7, 2025, aims to recognize past contributions and incentivize employees, aligning their interests with the company’s long-term goals and shareholder value. The share options, priced at HK$2.208 each, are intended to motivate continued commitment and performance, reflecting the company’s strategy to enhance employee engagement and loyalty.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.